ncRNADetailInformation

Detail Information
Functional analysis

miRNA name

pre-miRNA

family

pre-miRNA Sequence

mature-miRNA

mature sequence

pre-miRNA description

miR-200b

MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0000318 hsa-miR-200b-3p	UAAUACUGCCUGGUAAUGAUGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0004571 hsa-miR-200b-5p	CAUCUUACUGGGCAGCAUUGGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0000318 hsa-miR-200b-3p	UAAUACUGCCUGGUAAUGAUGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0004571 hsa-miR-200b-5p	CAUCUUACUGGGCAGCAUUGGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0000318 hsa-miR-200b-3p	UAAUACUGCCUGGUAAUGAUGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0004571 hsa-miR-200b-5p	CAUCUUACUGGGCAGCAUUGGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0000318 hsa-miR-200b-3p	UAAUACUGCCUGGUAAUGAUGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0004571 hsa-miR-200b-5p	CAUCUUACUGGGCAGCAUUGGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0000318 hsa-miR-200b-3p	UAAUACUGCCUGGUAAUGAUGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0004571 hsa-miR-200b-5p	CAUCUUACUGGGCAGCAUUGGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0000318 hsa-miR-200b-3p	UAAUACUGCCUGGUAAUGAUGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0004571 hsa-miR-200b-5p	CAUCUUACUGGGCAGCAUUGGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0000318 hsa-miR-200b-3p	UAAUACUGCCUGGUAAUGAUGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0004571 hsa-miR-200b-5p	CAUCUUACUGGGCAGCAUUGGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0000318 hsa-miR-200b-3p	UAAUACUGCCUGGUAAUGAUGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0004571 hsa-miR-200b-5p	CAUCUUACUGGGCAGCAUUGGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0000318 hsa-miR-200b-3p	UAAUACUGCCUGGUAAUGAUGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0004571 hsa-miR-200b-5p	CAUCUUACUGGGCAGCAUUGGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0000318 hsa-miR-200b-3p	UAAUACUGCCUGGUAAUGAUGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0004571 hsa-miR-200b-5p	CAUCUUACUGGGCAGCAUUGGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0000318 hsa-miR-200b-3p	UAAUACUGCCUGGUAAUGAUGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0004571 hsa-miR-200b-5p	CAUCUUACUGGGCAGCAUUGGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0000318 hsa-miR-200b-3p	UAAUACUGCCUGGUAAUGAUGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0004571 hsa-miR-200b-5p	CAUCUUACUGGGCAGCAUUGGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0000318 hsa-miR-200b-3p	UAAUACUGCCUGGUAAUGAUGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .
MI0000342	MIPF0000019	CCAGCUCGGGCAGCCGUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGUCUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG	MIMAT0000318 hsa-miR-200b-3p	UAAUACUGCCUGGUAAUGAUGA	The mature sequence shown here represents the most commonly cloned formfrom large-scale cloning studies .

link to database

TargetScanS 6.2 | MicroCosm | microRNA.org | miRNAMap 2.0

Interacted genes from RAID,miRTarBase

SMAD2,EP300,NFAT5,VEGFA,SUPV3L1,TCF7L1,KLF11,FLT1,GATA4,BMI1,TGFBR1,KLHL20,MATR3,WDR37,ETS1
more » SMAD2,EP300,NFAT5,VEGFA,SUPV3L1,TCF7L1,KLF11,FLT1,GATA4,BMI1,TGFBR1,KLHL20,MATR3,WDR37,ETS1,RASSF2,RNF2,PTPRD,ZEB2,FN1,BCL2,ERBB2IP,RIN2,RERE,E2F3,HOXB5,ZEB1,CCNE2,RND3,KDR,XIAP,BAD,VAC14,ELMO2,PTPN12,BAP1,SHC1,WASF3,CREB1,NOTCH1,SEPT7

KEGG pathways enriched for interacted genes

pathway name

pathway description

target genes enrich in pathway

p-value

hsa05200	Pathways in cancer	CCNE2,BCL2,VEGFA,TCF7L1,EP300,ETS1,FN1,BAD,XIAP,TGFBR1,E2F3,SMAD2,	3.23E-9
hsa05215	Prostate cancer	CCNE2,BCL2,TCF7L1,EP300,BAD,CREB1,E2F3,	5.48E-7
hsa04510	Focal adhesion	BCL2,VEGFA,SHC1,FLT1,KDR,FN1,BAD,XIAP,	4.56E-6
hsa05212	Pancreatic cancer	VEGFA,BAD,TGFBR1,E2F3,SMAD2,	1.21E-4
hsa04520	Adherens junction	TCF7L1,EP300,WASF3,TGFBR1,SMAD2,	1.58E-4

hsa05210	Colorectal cancer	BCL2,TCF7L1,BAD,TGFBR1,SMAD2,	2.22E-4
hsa05222	Small cell lung cancer	CCNE2,BCL2,FN1,XIAP,E2F3,	2.22E-4
hsa04370	VEGF signaling pathway	VEGFA,NFAT5,KDR,BAD,	2.52E-2
hsa05220	Chronic myeloid leukemia	SHC1,BAD,TGFBR1,E2F3,	2.52E-2
hsa04110	Cell cycle	CCNE2,EP300,E2F3,SMAD2,	1.05E-1
hsa04310	Wnt signaling pathway	TCF7L1,EP300,NFAT5,SMAD2,	1.75E-1
hsa05211	Renal cell carcinoma	VEGFA,EP300,ETS1,	2.74E-1
hsa04210	Apoptosis	BCL2,BAD,XIAP,	4.09E-1
hsa04350	TGF-beta signaling pathway	EP300,TGFBR1,SMAD2,	4.09E-1
hsa04916	Melanogenesis	TCF7L1,EP300,CREB1,	5.17E-1
hsa04060	Cytokine-cytokine receptor interaction	VEGFA,FLT1,KDR,TGFBR1,	7.11E-1
hsa04722	Neurotrophin signaling pathway	BCL2,SHC1,BAD,	7.70E-1
hsa04320	Dorso-ventral axis formation	NOTCH1,ETS1,	8.95E-1

Gene ontology terms enriched for interacted genes

GO terms

GO terms description

target genes enrich in GO term

p-value

GO:0007389	pattern specification process	TCF7L1,HOXB5,EP300,BMI1,NOTCH1,FLT1,GATA4,ZEB2,RNF2,VEGFA,TGFBR1,ZEB1,SMAD2,	4.68E-12
GO:0035295	tube development	BCL2,VEGFA,EP300,NOTCH1,FLT1,KDR,ZFPM2,GATA4,TGFBR1,ZEB2,SMAD2,	3.34E-10
GO:0003002	regionalization	RNF2,TCF7L1,HOXB5,BMI1,EP300,NOTCH1,GATA4,TGFBR1,ZEB2,SMAD2,	2.77E-9
GO:0009952	anterior/posterior pattern formation	RNF2,TCF7L1,HOXB5,EP300,NOTCH1,GATA4,TGFBR1,ZEB2,SMAD2,	4.04E-9
GO:0045935	positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process	TCF7L1,SHC1,EP300,NOTCH1,GATA4,CREB1,E2F3,VEGFA,NFAT5,ETS1,ZFPM2,TGFBR1,ZEB1,SMAD2,	7.04E-9

GO:0051173	positive regulation of nitrogen compound metabolic process	TCF7L1,SHC1,EP300,NOTCH1,GATA4,CREB1,E2F3,VEGFA,NFAT5,ETS1,ZFPM2,TGFBR1,ZEB1,SMAD2,	1.02E-8
GO:0042127	regulation of cell proliferation	BCL2,SHC1,BMI1,NOTCH1,FLT1,KDR,GATA4,E2F3,VEGFA,BAP1,KLF11,ETS1,TGFBR1,ZEB1,SMAD2,	1.18E-8
GO:0010557	positive regulation of macromolecule biosynthetic process	TCF7L1,SHC1,EP300,NOTCH1,GATA4,CREB1,E2F3,VEGFA,NFAT5,ETS1,ZFPM2,TGFBR1,ZEB1,SMAD2,	1.23E-8
GO:0031328	positive regulation of cellular biosynthetic process	TCF7L1,SHC1,EP300,NOTCH1,GATA4,CREB1,E2F3,VEGFA,NFAT5,ETS1,ZFPM2,TGFBR1,ZEB1,SMAD2,	2.14E-8
GO:0045941	positive regulation of transcription	TCF7L1,EP300,NOTCH1,GATA4,CREB1,E2F3,VEGFA,NFAT5,ETS1,ZFPM2,TGFBR1,ZEB1,SMAD2,	2.46E-8
GO:0009891	positive regulation of biosynthetic process	TCF7L1,SHC1,EP300,NOTCH1,GATA4,CREB1,E2F3,VEGFA,NFAT5,ETS1,ZFPM2,TGFBR1,ZEB1,SMAD2,	2.55E-8
GO:0010628	positive regulation of gene expression	TCF7L1,EP300,NOTCH1,GATA4,CREB1,E2F3,VEGFA,NFAT5,ETS1,ZFPM2,TGFBR1,ZEB1,SMAD2,	3.41E-8
GO:0010604	positive regulation of macromolecule metabolic process	BCL2,TCF7L1,SHC1,EP300,NOTCH1,GATA4,CREB1,E2F3,VEGFA,NFAT5,ETS1,ZFPM2,TGFBR1,ZEB1,SMAD2,	3.49E-8
GO:0045893	positive regulation of transcription, DNA-dependent	VEGFA,TCF7L1,EP300,NOTCH1,NFAT5,ETS1,ZFPM2,CREB1,GATA4,E2F3,ZEB1,SMAD2,	4.74E-8
GO:0045944	positive regulation of transcription from RNA polymerase II promoter	VEGFA,TCF7L1,EP300,NOTCH1,NFAT5,ETS1,ZFPM2,CREB1,GATA4,ZEB1,SMAD2,	5.08E-8
GO:0051254	positive regulation of RNA metabolic process	VEGFA,TCF7L1,EP300,NOTCH1,NFAT5,ETS1,ZFPM2,CREB1,GATA4,E2F3,ZEB1,SMAD2,	5.16E-8
GO:0030324	lung development	VEGFA,EP300,NOTCH1,KDR,ZFPM2,TGFBR1,SMAD2,	3.01E-7
GO:0030323	respiratory tube development	VEGFA,EP300,NOTCH1,KDR,ZFPM2,TGFBR1,SMAD2,	3.59E-7
GO:0006357	regulation of transcription from RNA polymerase II promoter	TCF7L1,EP300,NOTCH1,GATA4,CREB1,RNF2,VEGFA,KLF11,NFAT5,ETS1,ZFPM2,ZEB1,SMAD2,	3.93E-7
GO:0060541	respiratory system development	VEGFA,EP300,NOTCH1,KDR,ZFPM2,TGFBR1,SMAD2,	5.04E-7
GO:0035239	tube morphogenesis	BCL2,VEGFA,NOTCH1,FLT1,KDR,GATA4,ZEB2,	1.31E-6
GO:0007167	enzyme linked receptor protein signaling pathway	VEGFA,ERBB2IP,SHC1,FLT1,KDR,CREB1,TGFBR1,SMAD2,PTPRD,	3.87E-6
GO:0051272	positive regulation of cell motion	BCL2,VEGFA,FLT1,ETS1,KDR,TGFBR1,	7.47E-6
GO:0006355	regulation of transcription, DNA-dependent	TCF7L1,HOXB5,EP300,NOTCH1,RERE,GATA4,CREB1,E2F3,ZEB2,RNF2,VEGFA,KLF11,NFAT5,ETS1,ZFPM2,ZEB1,SMAD2,	9.12E-6
GO:0051252	regulation of RNA metabolic process	TCF7L1,HOXB5,EP300,NOTCH1,RERE,GATA4,CREB1,E2F3,ZEB2,RNF2,VEGFA,KLF11,NFAT5,ETS1,ZFPM2,ZEB1,SMAD2,	1.21E-5
GO:0008284	positive regulation of cell proliferation	BCL2,VEGFA,BMI1,SHC1,NOTCH1,FLT1,KDR,TGFBR1,E2F3,	1.56E-5
GO:0048598	embryonic morphogenesis	RNF2,HOXB5,NOTCH1,GATA4,TGFBR1,ZEB2,ZEB1,SMAD2,	1.99E-5
GO:0048754	branching morphogenesis of a tube	BCL2,VEGFA,NOTCH1,FLT1,KDR,	3.16E-5
GO:0043009	chordate embryonic development	HOXB5,EP300,ZFPM2,GATA4,TGFBR1,ZEB2,ZEB1,SMAD2,	3.23E-5
GO:0009792	embryonic development ending in birth or egg hatching	HOXB5,EP300,ZFPM2,GATA4,TGFBR1,ZEB2,ZEB1,SMAD2,	3.42E-5
GO:0001763	morphogenesis of a branching structure	BCL2,VEGFA,NOTCH1,FLT1,KDR,	5.28E-5
GO:0045449	regulation of transcription	TCF7L1,HOXB5,EP300,BMI1,NOTCH1,RERE,CREB1,GATA4,E2F3,ZEB2,RNF2,VEGFA,KLF11,NFAT5,ETS1,ZFPM2,TGFBR1,ZEB1,SMAD2,	7.78E-5
GO:0006350	transcription	TCF7L1,HOXB5,EP300,BMI1,NOTCH1,RERE,GATA4,CREB1,E2F3,ZEB2,RNF2,KLF11,NFAT5,ETS1,ZFPM2,ZEB1,SMAD2,	7.87E-5
GO:0043193	positive regulation of gene-specific transcription	NOTCH1,ETS1,CREB1,GATA4,SMAD2,	9.96E-5
GO:0048568	embryonic organ development	VEGFA,HOXB5,ZFPM2,GATA4,TGFBR1,ZEB1,	1.12E-4
GO:0048565	gut development	BCL2,NOTCH1,GATA4,TGFBR1,	1.36E-4
GO:0051270	regulation of cell motion	BCL2,VEGFA,FLT1,ETS1,KDR,TGFBR1,	1.92E-4
GO:0048514	blood vessel morphogenesis	VEGFA,NOTCH1,FLT1,KDR,ZFPM2,TGFBR1,	2.90E-4
GO:0007507	heart development	EP300,NOTCH1,ZFPM2,GATA4,TGFBR1,SMAD2,	3.16E-4
GO:0035282	segmentation	TCF7L1,BMI1,EP300,ZEB2,	3.24E-4
GO:0001666	response to hypoxia	BCL2,VEGFA,EP300,FLT1,TGFBR1,	5.23E-4
GO:0032583	regulation of gene-specific transcription	NOTCH1,ETS1,CREB1,GATA4,SMAD2,	5.23E-4
GO:0001568	blood vessel development	VEGFA,NOTCH1,FLT1,KDR,ZFPM2,TGFBR1,	5.76E-4
GO:0045165	cell fate commitment	BCL2,NOTCH1,KDR,TGFBR1,SMAD2,	6.00E-4
GO:0070482	response to oxygen levels	BCL2,VEGFA,EP300,FLT1,TGFBR1,	6.33E-4
GO:0001944	vasculature development	VEGFA,NOTCH1,FLT1,KDR,ZFPM2,TGFBR1,	6.43E-4
GO:0048547	gut morphogenesis	BCL2,NOTCH1,GATA4,	1.01E-2
GO:0051094	positive regulation of developmental process	BCL2,NOTCH1,ETS1,BAD,GATA4,SMAD2,	1.01E-2
GO:0010464	regulation of mesenchymal cell proliferation	VEGFA,KDR,ZEB1,	1.14E-2
GO:0006351	transcription, DNA-dependent	KLF11,NFAT5,ETS1,CREB1,GATA4,E2F3,	1.26E-2
GO:0032774	RNA biosynthetic process	KLF11,NFAT5,ETS1,CREB1,GATA4,E2F3,	1.34E-2
GO:0045927	positive regulation of growth	BCL2,EP300,CREB1,TGFBR1,	1.44E-2
GO:0055123	digestive system development	BCL2,NOTCH1,GATA4,	1.56E-2
GO:0048546	digestive tract morphogenesis	BCL2,NOTCH1,GATA4,	1.56E-2
GO:0048729	tissue morphogenesis	BCL2,TCF7L1,NOTCH1,ZEB2,SMAD2,	1.57E-2
GO:0051674	localization of cell	FLT1,ETS1,KDR,FN1,TGFBR1,ZEB2,	1.58E-2
GO:0048870	cell motility	FLT1,ETS1,KDR,FN1,TGFBR1,ZEB2,	1.58E-2
GO:0016481	negative regulation of transcription	RNF2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1,SMAD2,	1.62E-2
GO:0030335	positive regulation of cell migration	BCL2,VEGFA,FLT1,KDR,	1.96E-2
GO:0040008	regulation of growth	BCL2,EP300,SHC1,CREB1,GATA4,TGFBR1,	2.50E-2
GO:0008361	regulation of cell size	BCL2,ERBB2IP,EP300,CREB1,TGFBR1,	2.57E-2
GO:0040017	positive regulation of locomotion	BCL2,VEGFA,FLT1,KDR,	2.58E-2
GO:0010629	negative regulation of gene expression	RNF2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1,SMAD2,	2.59E-2
GO:0045934	negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process	RNF2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1,SMAD2,	2.80E-2
GO:0030856	regulation of epithelial cell differentiation	NOTCH1,TGFBR1,ZEB1,	2.97E-2
GO:0051172	negative regulation of nitrogen compound metabolic process	RNF2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1,SMAD2,	3.00E-2
GO:0045892	negative regulation of transcription, DNA-dependent	RNF2,KLF11,TCF7L1,ZFPM2,ZEB1,SMAD2,	3.01E-2
GO:0009798	axis specification	RNF2,TCF7L1,SMAD2,	3.18E-2
GO:0008285	negative regulation of cell proliferation	BCL2,BAP1,KLF11,ETS1,ZEB1,SMAD2,	3.20E-2
GO:0051253	negative regulation of RNA metabolic process	RNF2,KLF11,TCF7L1,ZFPM2,ZEB1,SMAD2,	3.24E-2
GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	VEGFA,ERBB2IP,SHC1,FLT1,KDR,	3.47E-2
GO:0060429	epithelium development	BCL2,VEGFA,HOXB5,KDR,ZEB2,	3.64E-2
GO:0045597	positive regulation of cell differentiation	BCL2,NOTCH1,ETS1,BAD,SMAD2,	3.75E-2
GO:0010558	negative regulation of macromolecule biosynthetic process	RNF2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1,SMAD2,	3.89E-2
GO:0006366	transcription from RNA polymerase II promoter	KLF11,NFAT5,ETS1,GATA4,E2F3,	4.06E-2
GO:0031327	negative regulation of cellular biosynthetic process	RNF2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1,SMAD2,	4.40E-2
GO:0009890	negative regulation of biosynthetic process	RNF2,KLF11,TCF7L1,ZFPM2,ZEB2,ZEB1,SMAD2,	4.88E-2
GO:0006796	phosphate metabolic process	BCL2,PTPN12,SHC1,FLT1,KDR,CREB1,TGFBR1,SMAD2,PTPRD,	4.89E-2
GO:0006793	phosphorus metabolic process	BCL2,PTPN12,SHC1,FLT1,KDR,CREB1,TGFBR1,SMAD2,PTPRD,	4.89E-2
GO:0007049	cell cycle	SEPT7,RNF2,CCNE2,BCL2,ERBB2IP,EP300,E2F3,RASSF2,	5.27E-2
GO:0051147	regulation of muscle cell differentiation	BCL2,NOTCH1,ZEB1,	5.33E-2
GO:0022604	regulation of cell morphogenesis	VEGFA,KDR,FN1,SMAD2,	5.84E-2
GO:0001541	ovarian follicle development	BCL2,VEGFA,KDR,	5.88E-2
GO:0001570	vasculogenesis	VEGFA,KDR,ZFPM2,	5.88E-2
GO:0048534	hemopoietic or lymphoid organ development	BCL2,VEGFA,BMI1,KDR,TGFBR1,	5.89E-2
GO:0048562	embryonic organ morphogenesis	HOXB5,GATA4,TGFBR1,ZEB1,	6.09E-2
GO:0042981	regulation of apoptosis	BCL2,VEGFA,NOTCH1,ETS1,BAD,CREB1,XIAP,TGFBR1,	6.38E-2
GO:0043067	regulation of programmed cell death	BCL2,VEGFA,NOTCH1,ETS1,BAD,CREB1,XIAP,TGFBR1,	6.73E-2
GO:0032535	regulation of cellular component size	BCL2,ERBB2IP,EP300,CREB1,TGFBR1,	6.80E-2
GO:0010941	regulation of cell death	BCL2,VEGFA,NOTCH1,ETS1,BAD,CREB1,XIAP,TGFBR1,	6.86E-2
GO:0016477	cell migration	FLT1,KDR,FN1,TGFBR1,ZEB2,	7.25E-2
GO:0002520	immune system development	BCL2,VEGFA,BMI1,KDR,TGFBR1,	7.25E-2
GO:0001525	angiogenesis	VEGFA,NOTCH1,FLT1,KDR,	8.18E-2
GO:0016202	regulation of striated muscle tissue development	BCL2,NOTCH1,GATA4,	8.64E-2
GO:0014031	mesenchymal cell development	BCL2,NOTCH1,ZEB2,	8.98E-2
GO:0048634	regulation of muscle development	BCL2,NOTCH1,GATA4,	8.98E-2
GO:0048762	mesenchymal cell differentiation	BCL2,NOTCH1,ZEB2,	8.98E-2
GO:0060485	mesenchyme development	BCL2,NOTCH1,ZEB2,	9.32E-2
GO:0042325	regulation of phosphorylation	CCNE2,BCL2,SHC1,FLT1,TGFBR1,ZEB2,	9.33E-2
GO:0008360	regulation of cell shape	VEGFA,KDR,FN1,	1.00E-1
GO:0006468	protein amino acid phosphorylation	BCL2,SHC1,FLT1,KDR,CREB1,TGFBR1,SMAD2,	1.00E-1
GO:0006928	cell motion	FLT1,ETS1,KDR,FN1,TGFBR1,ZEB2,	1.00E-1

KEGG pathways and Gene Ontology terms enriched for the interacted genes of ncRNA from RAID and miRTarBase.

disease name	related genes	p-value